Hospitals / providers

Europe’s Preventable RSV Winter
New ECDC modelling suggests that protecting newborns against RSV could prevent a substantial share of infant hospitalisations during the first months of life. Under a scenario reaching 90% of newborns with long-acting monoclonal antibodies, 61% of RSV hospitalisations in the first two months could be prevented. Europe has the preventive tools. The challenge is making…

Europe Has Plans. Implementation Is Lagging

A Self-Guided Pathway for Functional Seizures

Barbados Made HIV Prevention Work

Schizophrenia Gets a Five-Day Brain-Stimulation Signal

The Mystery Patient Found The Gaps

Skin Cancer AI Has Crossed a Line: It Is Discharging Patients on Its Own

Genomics Is Becoming an Acute Neurology Test

Low magnesium may be more than a lab abnormality in emergency care

CLL Just Moved a Noncovalent BTK Inhibitor Into First Line
Free IPM Alliance Newsletter
Insights on science, policy and access in personalised medicine.
